Metabolic Approaches to Chronic Liver Disease

Mar 01–04, 2027 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Jay D. Horton, Bei B. Zhang, and Samuel Klein

  Livestream
  In Person
  On Demand
 Add to Calendar
×

-

Mar 01–04, 2027 | Keystone Resort, Keystone, CO, United States

Scientific Organizers: Jay D. Horton, Bei B. Zhang, and Samuel Klein

Supported by:

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Monday, March 1, 2027
Registration  
4:00–8:00 PM
 Longs Peak Foyer
Welcome Mixer  
6:00–8:00 PM
 Longs Peak Foyer
Tuesday, March 2, 2027
Breakfast  
7:00–8:00 AM
 Quandary Peak
Welcome Remarks      
8:00–8:10 AM
 Grays Peak
Keynote Address      
8:10–9:00 AM
 Grays Peak
Helen H. Hobbs, University of Texas Southwestern Medical Center
Genetic Determinants of Chronic Liver Disease Progression
Role of Intrahepatic Lipid Metabolism in Steatotic Liver Diseases      
9:00–11:30 AM
 Grays Peak
Jay D. Horton, University of Texas Southwestern Medical Center
Role of Intrahepatic Lipid Metabolism in Steatotic Liver Diseases
Peter A. Crawford, Baylor College of Medicine
Ketogenesis and Fatty Acid Synthesis
Kathryn E. Wellen, University of Pennsylvania
New and Surprising Directions in de novo Lipogenesis
Brian N. Finck, Washington University
From Energy to Remedy: Targeting Mitochondrial Metabolism
Coffee Break  
9:30–9:50 AM
 Longs Peak Foyer
Panel Discussion 1: What will be the Residual Risk if Patients are Placed in Incretin Therapy for Obesity? Then, What is the Residual Risk in MASH?      
11:40–12:25 PM
 Grays Peak
Poster Setup  
12:25–1:00 PM
 Quandary Peak
On Own for Lunch  
12:25–2:30 PM
Poster Viewing  
1:00–10:00 PM
 Quandary Peak
Symposia Spotlight 1      
2:30–4:30 PM
 Grays Peak
Short Talks Chosen from Abstracts
Coffee Available  
4:30–5:00 PM
 Longs Peak Foyer
Molecular Drivers of Chronic Liver Disease      
5:00–7:00 PM
 Grays Peak
Ana Maria Cuervo, Albert Einstein College of Medicine
Role of Autophagy in Chronic Liver Disease
Shuang Wang, Mount Sinai
Role of Endothelium in MASH Progression and Regression
Orian S Shirihai, David Geffen School of Medicine at UCLA
Mitochondrial Function in Chronic Liver Disease
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner  
7:00–8:00 PM
 Quandary Peak
Poster Session 1  
7:30–10:00 PM
 Quandary Peak
Wednesday, March 3, 2027
Breakfast  
7:00–8:00 AM
 Quandary Peak
Emerging Therapeutic Approaches to Treat Chronic Liver Diseases      
8:00–11:00 AM
 Grays Peak
Bei B. Zhang, Novo Nordisk
Unraveling Complex Biology and Improving Cardiometabolic Health with New Therapies
Ginnie Yang, Wave Life Sciences USA, Inc.
Unlocking the Potential of RNA Medicines for Metabolic and Hepatic Disorders
Katrin J. Svensson, Stanford University
Role of Non-Incretin Peptides in Obesity and MASLD
Gerald I Shulman, Yale School of Medicine
Targeting Hepatic Mitochondria: Liver-Directed Protonophores for the Treatment of MASLD and MASH
Short Talk(s) Chosen from Abstracts
Coffee Break  
9:00–9:20 AM
 Longs Peak Foyer
Poster Setup  
11:00–1:00 PM
 Quandary Peak
Panel Discussion 2: Is Weight Loss Induced Loss in Muscle Mass a Problem?      
11:10–12:10 PM
 Grays Peak
On Own for Lunch  
12:10–3:00 PM
Poster Viewing  
1:00–10:00 PM
 Quandary Peak
Career Roundtable  
3:00–4:30 PM
 Longs Peak
Coffee Available  
4:30–5:00 PM
 Longs Peak Foyer
Peripheral Organ Contribution and Pathogenesis of Liver Fibrosis      
5:00–7:00 PM
 Grays Peak
David A Brenner, Sanford Burnham Prebys
Molecular Events Leading to Stellate Cell Activation and Fibrosis in Chronic Liver Disease
Timo D Müller, Helmholtz Munich
Improving Liver Health using Next Generation Incretin-Based Polyagonists
Liming Pei, Children's Hospital of Philadelphia/University of Pennsylvania
Pathogenesis and Mechanisms Underlying Fontan-Associated Liver Disease (FALD)
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner  
7:00–8:00 PM
 Quandary Peak
Poster Session 2  
7:30–10:00 PM
 Quandary Peak
Thursday, March 4, 2027
Breakfast  
7:00–8:00 AM
 Quandary Peak
Weight Loss and Exercise in MASLD Progression      
8:00–11:00 AM
 Grays Peak
Samuel Klein, Washington University School of Medicine
Metabolic and Hepatic Implications of Weight Loss
Juleen R. Zierath, Karolinska Institutet
Exercise Medicine for MASLD
Amalia Gastaldelli, Institute of Clinical Physiology, CNR
Linking Glucose Metabolism to MASLD Progression
Short Talk(s) Chosen from Abstracts
Coffee Break  
9:00–9:20 AM
 Longs Peak Foyer
On Own for Lunch  
11:00–2:30 PM
Symposia Spotlight 2      
2:30–4:30 PM
 Grays Peak
Short Talks Chosen from Abstracts
Coffee Available  
4:30–5:00 PM
 Longs Peak Foyer
Role of Peripheral Organs in Chronic Liver Disease Progression      
5:00–6:15 PM
 Grays Peak
Caterina Conte, San Raffaele Roma University, Rome, Italy
Sarcopenia in Obesity and MASLD: Definition and Clinical Implications
Saswata Talukdar, Roche
Effect of Myostatin and Activin Inhibition on Muscle Mass, Strength and Function
Short Talk(s) Chosen from Abstracts
Closing Keynote Address      
6:15–7:05 PM
 Grays Peak
Jens C. Brüning, Max Planck Institute for Metabolism Research
Role of Hypothalamus in MASLD
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)      
7:05–7:15 PM
 Grays Peak
Social Hour with Dinner  
7:15–8:15 PM
 Quandary Peak
Entertainment  
8:00–9:00 PM
 Quandary Peak
Cash Bar  
8:00–9:00 PM
 Quandary Peak
Friday, March 5, 2027
Departure  
12:00–11:59 PM

Subscribe for Updates